Compare Equinix Inc (EQIX) vs HCA Health Inc (HCA) Price & Performance

Equinix (EQIX) trades at $1,005.31, down 1.78% today, with a bearish technical signal despite strong analyst support. The company reported mixed Q1 2026 earnings with a slight miss on EPS expectations but maintains robust revenue growth and profitability. Recent partnerships with Cisco and NVIDIA position EQIX well for AI infrastructure demand, though high valuation ratios and negative cash flow trends present challenges.

The outlook remains cautiously optimistic with 74.5% analyst buy ratings and a $1,110 consensus price target suggesting 10% upside. Key risks include elevated debt levels, aggressive capital expenditure, and competitive pressures in the data center REIT sector. The stock offers exposure to digital infrastructure growth but requires monitoring of cash flow sustainability.

HCA Healthcare (HCA) trades at $389.90, up 7.23% over the past 24 hours, with strong recent earnings beats but a bearish technical signal. The stock shows solid fundamentals with 2025 revenue of $75.60B and net income of $6.78B, supported by a P/E of 13.05 and net margin of 8.89%. However, recent news highlights guidance cuts due to payer mix shifts and rising uninsured patients, creating near-term headwinds.

The outlook is mixed: analyst consensus remains bullish with a $469.40 price target, but technical indicators and recent guidance reductions suggest caution. Key risks include margin compression and debt levels, while long-term growth drivers like capacity expansion and gene therapy research offer potential upside. Investors should weigh strong valuation metrics against operational challenges.